NCAPG2 and neoplasm: Furthermore, IHC analysis of subcutaneous tumors indicated that NCAPG2 knockdown led to reduction in the level of c-MYC, following tumor shrinkage in vivo (Welch’s t-test P < 0.01, Additional file 1: Figure S7g).